Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Reexamination Certificate
2005-08-17
2009-10-06
Monshipouri, Maryam (Department: 1656)
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
C604S272000, C606S167000, C606S185000, CD24S130000
Reexamination Certificate
active
07597687
ABSTRACT:
A method of treating a disc that is leaking nucleus pulposus through at least one defect in the annulus fibrosus. The method includes injecting a fibrin sealant into the disc to reduce at least a portion of the at least one defect, wherein the fibrin sealant injected into the disc comprises an anesthetic, fibrinogen and an activating compound, wherein at least a portion of the fibrin forms after injection, with the proviso that a corticosteroid is absent from the fibrin sealant injected into the disc.
REFERENCES:
patent: 2533004 (1950-12-01), Ferry et al.
patent: 3089815 (1963-05-01), Lieb et al.
patent: 4359049 (1982-11-01), Redl et al.
patent: 4393041 (1983-07-01), Brown et al.
patent: 4427650 (1984-01-01), Stroetmann
patent: 4442655 (1984-04-01), Stroetmann
patent: 4619913 (1986-10-01), Luck et al.
patent: RE33375 (1990-10-01), Luck et al.
patent: 5124155 (1992-06-01), Reich
patent: 5264446 (1993-11-01), Hegasy et al.
patent: 5290552 (1994-03-01), Sierra et al.
patent: 5643192 (1997-07-01), Hirsh et al.
patent: 5651982 (1997-07-01), Marx
patent: 5702715 (1997-12-01), Nikolaychik et al.
patent: 5925738 (1999-07-01), Miekka et al.
patent: 5962420 (1999-10-01), Edwardson et al.
patent: 5980504 (1999-11-01), Sharkey et al.
patent: 5980866 (1999-11-01), Uchida et al.
patent: 6007570 (1999-12-01), Sharkey et al.
patent: 6007811 (1999-12-01), Sawyer et al.
patent: 6054122 (2000-04-01), MacPhee et al.
patent: 6073051 (2000-06-01), Sharkey et al.
patent: 6095149 (2000-08-01), Sharkey et al.
patent: 6117425 (2000-09-01), MacPhee et al.
patent: 6122549 (2000-09-01), Sharkey et al.
patent: 6124273 (2000-09-01), Drohan et al.
patent: 6126682 (2000-10-01), Sharkey et al.
patent: 6183518 (2001-02-01), Ross et al.
patent: 6197325 (2001-03-01), MacPhee et al.
patent: 6224630 (2001-05-01), Bao et al.
patent: 6258086 (2001-07-01), Ashley et al.
patent: 6261311 (2001-07-01), Sharkey et al.
patent: 6320029 (2001-11-01), Miekka et al.
patent: 6428576 (2002-08-01), Haldimann
patent: 6468527 (2002-10-01), Austin et al.
patent: 6503527 (2003-01-01), Whitmore et al.
patent: 6517568 (2003-02-01), Sharkey et al.
patent: 6547810 (2003-04-01), Sharkey et al.
patent: 6559119 (2003-05-01), Burgess et al.
patent: 6638276 (2003-10-01), Sharkey et al.
patent: RE38431 (2004-02-01), Miekka et al.
patent: 6726685 (2004-04-01), To et al.
patent: 6733496 (2004-05-01), Sharkey et al.
patent: 6749605 (2004-06-01), Ashley et al.
patent: 6762336 (2004-07-01), MacPhee et al.
patent: 6764467 (2004-07-01), Roby et al.
patent: 6767347 (2004-07-01), Sharkey et al.
patent: 6780411 (2004-08-01), Lewis, Jr. et al.
patent: 6921532 (2005-07-01), Austin et al.
patent: 7004945 (2006-02-01), Boyd et al.
patent: 2002/0110554 (2002-08-01), Lewis, Jr. et al.
patent: 2003/0091558 (2003-05-01), Woolverton
patent: 2003/0181964 (2003-09-01), Sharkey et al.
patent: 2004/0111136 (2004-06-01), Sharkey et al.
patent: 2004/0191261 (2004-09-01), Redl et al.
patent: 2004/0192658 (2004-09-01), Hunter et al.
patent: 2004/0193151 (2004-09-01), To et al.
patent: 3037270 (1982-05-01), None
patent: 0 068 149 (1982-05-01), None
patent: WO81/00516 (1981-03-01), None
patent: WO92/22312 (1992-12-01), None
patent: WO94/20133 (1994-09-01), None
patent: WO96/17633 (1996-06-01), None
patent: WO97/42986 (1997-11-01), None
patent: WO01/97872 (2001-12-01), None
US 6,645,204, 12/2002, Sharkey et al. (withdrawn)
Lutz, G.E., et al. 1998 Arch Phys Med Rehabil 79: 1362-1366.
Abstract: T. Yagita, “Agent for Controlling Formation of Cheloid at Excision Site for Inflammation Bowel Disease” Feb. 10, 1997; Database WPI, Section Ch, Week 199716, Derwent Publications Ltd., London, GB XP002182938.
Abstract: Sumitomo Cement Co., “Sustained Release Agent for Treatment of Osteomyelitis” Jan. 8, 1993; Database WPI, Section Ch, Week 199306, Derwent Publications Ltd., London, GB XP002182939.
G. Y. Bong et al., “Development of Local Antibiotic Delivery System Using Fibrin Glue” Mar. 1, 1996; Journal of Controlled Release, Elsevier Science Publishers, vol. 29, No. 1, pp. 65-70.
J. Rousou et al., “Randomized Clinical Trial of Fibrin Sealant in Cardiac Surgery Patients Undergoing Resternotomy” Feb. 1989; Journal of Thoracic and Cardiovascular Surgery; vol. 97, No. 2, pp. 194-203.
P. Knoringer, “Fibrin Sealing in Spinal Neurosurgery” 1986.
P.M. McCarthy et al., “Fibrin Sealant: The Cleveland Clinic Experience” 1991.
M. Dahan et al., “The Importance of Biological Glue for the Prevention of Air Leakage in Pulmonary Surgery” 1991; Materials and Methods, pp. 113-116.
H. W. Waclawiczek, “Fibrin Sealing in Liver and Spleen Surgery” 1994.
C. Shaffey et al., “Neurosurgical Applications of Fibrin Glue: Augmentation of Dural Closure in 134 Patients” 1990; Neurosurgery, vol. 26, No. 2, pp. 207-210.
M. Acqui et al., “Our Experience With Human Fibrin Glue in Neurological Procedures” Date unknown.
A. Hjortrup, M.D. et al., “Fibrin Adhesive in Perineal Fistulas” Sep. 1991; from the Dept. of Surgical Gastroenterology F, Bispebjerg Hospital and Dept. of Surgical Gastroenterology C, Rigsbospitalet, University of Copenhagen, Copenhagen, Denmark, vol. 34, No. 9.
T. M. Kieser et al., “Reduced Postoperative Bleeding Following Use of Tisseel Fibrin Sealant in 300 Patients undergoing Open-Heart Surgery” date unknown.
W. D. Sponitz, M.D. et al., “Clinical Uses of Fibrin Sealant” 1999; Transfusion Therapy: Clinical Principles and Practice, Bethesda, MD: AABB Press.
N. Tajima et al., “Bone Grafts Using Fibrin Glue for Posterolateral Spinal Fusion and Total Hip Replacement with Central Migration” date unknown.
G. E. Lutz et al., “Flouroscopic Transforaminal Lumbar Epidural Steroids: An Outcome Study” Nov. 1998; Arch Phys Med Rehabil, vol. 79, pp. 18-21.
P. Goupille et al., “The Role of Inflammation in Disk Herniation-Associated Radiculopathy” Aug. 28, 1998; Semin Arthritis Rheum, (1):60-71.
J. D. Kang et al., “Herniated Lumbar Intervertebral Discs Spontaneously Produce Matrix Metalloproteinases, Nitric Oxide, Interleukin-6, and Prostaglandin E2” Feb. 1, 1996; Spine, 21(3): 271-7.
J. S. Saal et al., “High Levels of Inflammatory Phospholipase A2 Activity in Lumbar Disc Herniations” Jul. 1990; Spine, 15(7): 674-8.
O. P. Nygaard et al., “The Inflammatory Properties of Contained and Noncontained Lumbar Disc Herniation” Nov. 1, 1997; Spine, 22(21): 2484-8.
H. Takahashi et al., “Inflammatory Cytokines in the Herniated Disc of the Lumbar Spine” Jan. 15, 1996; Spine, 21(2):218-24.
Product Information, “Celestone Soluspan”, brand of betamethasone sodium phosphate and betamethasone acetate Injectable Suspension, USP 6 mg. per mL, Schering Corporation, Kenilworth, N.J. 07033 USA, Rev. Mar. 1996.
Product Information, “Fibrin Sealant Hemaseel APR Kit, Two Component Fibrin Sealant, Vapor Heated, Kit” Manufactured for and Distributed by Haemacure Corp., 2 N. Tamiami Trail, Suite 802, Sarasota, FL 34236, Issued May 1998.
PCT International Search Report, PCT/US05/39277, Jun. 6, 2006.
Burkinshaw Brian D.
Pauza Kevin
Richards Mark I.
Rogan James B.
Whitlock Steven I.
Monshipouri Maryam
O'Keefe, Egan Peterman & Enders LLP
Spinal Restoration, Inc.
Tsay Marsha M
LandOfFree
Injection of fibrin sealant including an anesthetic in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injection of fibrin sealant including an anesthetic in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injection of fibrin sealant including an anesthetic in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4067210